Ever undergone reconstructive orthopedic surgery? Yes, then you may have been implanted with one of the personalized joint replacement technologies of Indiana-based, one of the leading orthopedic medical devices manufacturer–Zimmer Holdings, Inc. (ZMH). With operations in more than 25 countries, the company markets its orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products in more than 100 countries.

Currently, Zimmer Holdings has a Zacks Rank #3 (Hold) but that could change following its fourth-quarter and full-year 2014 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: Zimmer’s adjusted earnings per share increased by 3% on a year-over-year basis to $1.71. It also managed to beat the Zacks Consensus Estimate of $1.70.

Sales: Zimmer’s sales fell 1% on a year-over-year basis to $1.22 billion, which is lower than the Zacks Consensus Estimate of $1.24 billion.

Key Stats: Revenues derived from Zimmer’s Knees segment were down 1% year over year to $519 million, while Hips recorded sales of $338 million, down 4% compared with the prior-year quarter. Revenues from Extremities increased 4% year over year to $54 million.

Major Factors: The impending $13.35 billion acquisition of Biomet, which Zimmer expects to complete in the first quarter of 2015, is expected to make Zimmer a market leader in the $45 billion musculoskeletal industry thereby improving the merged entity's position in the competitive niche. Per management this buyout will be beneficial for healthcare investors as the merged entity will successfully advance innovation and help create a more diversified and predictable revenue mix consistent with the comprehensive portfolio

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this Zimmer Holdings earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ZIMMER HOLDINGS (ZMH): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research